“Maybe Black History Month should be more centered around the contributions of Black Americans—what they have contributed to what this country is. I would love to know more about that.”

"By year’s end, brittle with guilt, we hovered over our hollow creation..."

Names can hurt, and they can lead to broken bones.

Charles Montano, MD, and Carmen Kosicek, MSN, PMHNP-BC, comment on the impact of various classes of MDD treatments on time to achieve goals and/or response.

Check out this winner of the 2022 Sigourney Award!

Could police brutality be part of a larger legacy of American trauma transmission?

"If it bleeds, it leads..."

The 2022 Sigourney Award winner reflects on her work.

“Anyone who cares about patients is doomed to burnout.”

In honor of Black History Month, Psychiatric Times™ highlights the contributions of Black clinicians to the field of psychiatry, as well as issues that continue to impact this underrepresented community.

Are your patients ready to honor the time commitment for friendship? It can be as easy as 8 minutes.

The experts weighed in on a wide variety of psychiatric issues for the January 2023 issue of Psychiatric Times.

“Bringing us home, To ourselves, Our selves, Our bodies, our shelters…”

Should we try to be the keepers of our brothers and sisters?

How can you get involved and be more knowledgeable about social psychiatry?

A psychiatric reflects on the latest news and remembers Tyre Nichols.

From special issues in diagnosing and treating catatonia to helping justice-involved individuals re-enter the community, here are highlights from the week in Psychiatric Times.

No good deed goes unpunished...

The agency’s conclusions are based on regulatory oversight needed to manage risks associated with CBD and other cannabis-derived products.

"I wish I could have caught his eye, delivered the silent message that I understood what he had to go through every day to keep the peace..."

Be on the lookout for anti-Semitic messages.

Carmen Kosicek, MSN, PMHNP-BC, leads a discussion on the level of satisfaction for both patients and providers with currently available MDD treatment options, barriers to access, and the impact of residual symptoms on a patient’s quality of life.

Experts in psychiatry share their treatment approaches for the management of episodic and chronic MDD.

Charles Montano, MD, and Carmen Kosicek, MSN, PMHNP-BC, review currently available treatment options for the management of MDD and criteria used for treatment selection.